EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Colorectal cancer prevalence in faecal immunochemical test non-returners: potential for health inequality in symptomatic referral pathways

Adam D Gerrard iD, Jonty Coxon, Yasuko Maeda iD, Evropi Theodoratou iD, Malcolm G Dunlop iD, Farhat V N Din

BJS Open · 2024

DOI: 10.1093/bjsopen/zrae119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJS Open, 2024. Verfasst von Adam D Gerrard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Referral and Consultation, Occult Blood, Early Detection of Cancer. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chief Scientist Office, Scotland, Cancer Research UK, Scottish Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to describe the faecal immunochemical test non-return rate of those referred with high-risk symptoms of colorectal cancer from primary care, and the clinical outcomes of the ‘non-returners’.

Methods

From January 2019 to July 2021, patients referred to secondary care with symptoms suspicious of colorectal cancer and a referral priority of urgent or urgent suspicion of cancer were sent a faecal immunochemical test. All patients were investigated regardless of faecal immunochemical test return or result. Demographics and clinical outcomes such as colorectal cancer prevalence were compared between those who returned a faecal immunochemical test and non-returners.

Results

Of 7345 patients included in the study, 874 (11.9%) did not return a faecal immunochemical test. Non-returner characteristics included male sex (P = 0.040), younger age (median age 57 versus 65 years, P < 0.001), per rectal bleeding (P < 0.001) and lower socioeconomic status (median Scottish Index of Multiple Deprivation, 6 versus 7, P < 0.001) compared with those who returned a faecal immunochemical test. Of 6294 patients undergoing colorectal investigation, there was a greater prevalence of colorectal cancer (5.4% versus 3.6% P = 0.032) and significant bowel pathology than in the non-returners (15.3% versus 9.8%, P < 0.001). With a median follow-up of 25 months, the colorectal cancer prevalence for the entire 7345 cohort was equal between those who returned and did not return a faecal immunochemical test (3.2% versus 3.8%, P = 0.108). Of note, the non-returners diagnosed with colorectal cancer were younger (median age 64 versus 73 years, P < 0.001) and from a lower socioeconomic area (median Scottish Index of Multiple Deprivation 4 versus 7, P = 0.015) than faecal immunochemical test returners.

Conclusion

Patients referred to secondary care, with symptoms suspicious of colorectal cancer, that did not return a faecal immunochemical test had a similar colorectal cancer prevalence to those that returned the test.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsReferral and ConsultationOccult BloodEarly Detection of CancerHumansMaleFemaleMiddle AgedAgedPrevalenceScotlandFecesImmunochemistryHealthcare DisparitiesAdultPrimary Health Care

Autor:innen und Institutionen

  • Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Department of Colorectal Surgery, Western General Hospital, Edinburgh, UK.
  • Department of Surgery, Queen Elizabeth University Hospital, Glasgow, UK.
  • Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK.
  • UK Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics & Cancer, Western General Hospital, University of Edinburgh, Edinburgh, UK.

ORCID-Profile: Adam D Gerrard, Yasuko Maeda, Evropi Theodoratou, Malcolm G Dunlop

Förderung

  • Chief Scientist Office, Scotland
  • Cancer Research UK
  • Scottish Government
  • CRUK Career Development Fellowship

Zitieren

APA

Gerrard, A. D., Coxon, J., Maeda, Y., Theodoratou, E., Dunlop, M. G., & Din, F. V. N. (2024). Colorectal cancer prevalence in faecal immunochemical test non-returners: potential for health inequality in symptomatic referral pathways. BJS Open. https://doi.org/10.1093/bjsopen/zrae119

Vancouver

Gerrard AD, Coxon J, Maeda Y, Theodoratou E, Dunlop MG, Din FVN. Colorectal cancer prevalence in faecal immunochemical test non-returners: potential for health inequality in symptomatic referral pathways. BJS Open. 2024. doi:10.1093/bjsopen/zrae119

BibTeX
@article{Gerrard2024,
  author = {Gerrard, Adam D and Coxon, Jonty and Maeda, Yasuko and Theodoratou, Evropi and Dunlop, Malcolm G and Din, Farhat V N},
  title = {Colorectal cancer prevalence in faecal immunochemical test non-returners: potential for health inequality in symptomatic referral pathways},
  journal = {BJS Open},
  year = {2024},
  doi = {10.1093/bjsopen/zrae119}
}
Kostenlos starten →